本文报道了7个国家的20个研究者采用Cefadroxil(一种新的口服的头孢菌素)对由固紫染色阳性与阴性菌引起上、下呼吸道感染的成人与儿童患者进行治疗的结果,表明其疗效显著,且使用安全。治疗对象共363例,男性201例,女性162例。成人294例,儿童69例,77%患者系中度感染,20%是严重感染,轻度者仅占3%。 This article reports the results of 20 researchers using Cefadroxil (a new oral cephalosporin) in adult and pediatric patients with upper and lower respiratory tract infections caused by solid-purple stains of positive and negative bacteria, reported by 20 researchers in seven countries Its significant effect, and the use of safety. The treatment of a total of 363 cases, 201 males and 162 females. There were 294 adults, 69 children and 77% moderate infections, 20% were severe infections and only 3% were mild.